4:58 PM ET
8-K
Loan & Debt
Nuo Therapeutics Debt Financing Update with Scott M. Pittman
Nuo Therapeutics entered into an amendment to its Amended and Restated Loan and Security Agreement to close a second funding tranche of $325,000. The company has now received an aggregate of $2.0 million under the facility, with the new notes bearing 12% interest and maturing on December 31, 2028. The funding involved the joinder of three new lenders and an additional commitment from director Scott M. Pittman.
- Counterparty
- Scott M. Pittman
- Term
- through Dec 2028